In vitro proteolytic cleavage of Gazdar murine sarcoma virus p65gag

Journal of Virology
|September 1, 1981
PubMed

Insights

Moloney murine leukemia virus processing of a murine sarcoma virus polyprotein was studied. The virus catalyzed cleavage into specific polypeptides, revealing key viral protein structures.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Moloney murine leukemia virus (MMLV) is a retrovirus.
  • Murine sarcoma virus (MSV) encodes a gag gene polyprotein, p65.
  • Understanding retroviral polyprotein processing is crucial for viral replication and pathogenesis.

Purpose of the Study:

  • To investigate the in vitro cleavage of the MSV gag polyprotein (p65) by MMLV.
  • To characterize the resulting polypeptide products and their antigenic determinants.

Main Methods:

  • In vitro cleavage assays using MMLV and MSV p65 in varying Nonidet P-40 concentrations and buffered solutions.
  • Analysis of polypeptide products by size (Mr) and immunoprecipitation with monospecific sera.

Main Results:

  • MMLV catalyzed the cleavage of p65 into polypeptides antigenically related to MMLV structural proteins (p30, p15, pp12, p10).
  • Cleavage in buffer with dithiothreitol yielded P40 (containing p30 and p10) and P25 (containing p15 and pp12).
  • P40 and P25 resemble previously identified gag-related precursors in infected cells.

Conclusions:

  • MMLV possesses enzymatic activity capable of processing the MSV gag polyprotein in vitro.
  • The cleavage products share antigenic determinants with mature MMLV structural proteins.
  • This study provides insights into retroviral polyprotein maturation and potential mechanisms of viral protein synthesis.

Related Concept Videos